UNICA IRIS Institutional Research Information System

MELONI, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 65.101
NA - Nord America 1.965
AS - Asia 1.090
SA - Sud America 145
AF - Africa 44
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 1
Totale 68.372
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 64.463
US - Stati Uniti d'America 1.898
SG - Singapore 395
CN - Cina 316
SE - Svezia 156
BR - Brasile 115
GB - Regno Unito 101
VN - Vietnam 96
DE - Germania 87
FR - Francia 60
FI - Finlandia 46
CA - Canada 44
IN - India 43
KR - Corea 41
UA - Ucraina 39
HK - Hong Kong 35
NL - Olanda 27
AU - Australia 22
TW - Taiwan 22
ES - Italia 21
TR - Turchia 19
IQ - Iraq 17
IR - Iran 16
JP - Giappone 15
RO - Romania 14
ZA - Sudafrica 14
AT - Austria 13
PH - Filippine 13
IE - Irlanda 12
MX - Messico 12
MY - Malesia 10
RU - Federazione Russa 10
AR - Argentina 9
CZ - Repubblica Ceca 8
EG - Egitto 8
PL - Polonia 8
SA - Arabia Saudita 8
VE - Venezuela 7
CH - Svizzera 6
IL - Israele 6
KE - Kenya 6
BD - Bangladesh 5
BE - Belgio 5
MA - Marocco 5
TH - Thailandia 5
ET - Etiopia 4
NZ - Nuova Zelanda 4
PK - Pakistan 4
PT - Portogallo 4
RS - Serbia 4
TN - Tunisia 4
UZ - Uzbekistan 4
AL - Albania 3
GR - Grecia 3
ID - Indonesia 3
LB - Libano 3
LV - Lettonia 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
BG - Bulgaria 2
CL - Cile 2
CO - Colombia 2
EC - Ecuador 2
JM - Giamaica 2
JO - Giordania 2
MT - Malta 2
NP - Nepal 2
PE - Perù 2
UY - Uruguay 2
AM - Armenia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EU - Europa 1
GD - Grenada 1
GP - Guadalupe 1
HN - Honduras 1
HR - Croazia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
PA - Panama 1
PS - Palestinian Territory 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TT - Trinidad e Tobago 1
Totale 68.372
Salva come PNG Salva come JPEG
Città #
Cagliari 63.322
Uta 876
Singapore 226
Ashburn 201
Chandler 158
San Jose 120
Fairfield 117
Nyköping 97
Boardman 85
Dallas 83
Beijing 72
New York 63
Woodbridge 60
Houston 56
Shanghai 54
Augusta 52
Seattle 52
Wilmington 49
Ann Arbor 48
Los Angeles 48
Cambridge 37
Helsinki 37
Seoul 37
Dearborn 36
Santa Clara 34
Ho Chi Minh City 31
Redwood City 30
The Dalles 28
Hong Kong 26
Hanoi 24
Lauterbourg 22
Jacksonville 20
Council Bluffs 18
Frankfurt am Main 17
Buffalo 16
London 16
São Paulo 16
Boston 15
Atlanta 13
Munich 13
Orem 13
Dublin 12
Stockholm 12
Amsterdam 11
Baghdad 11
Finale Ligure 11
Hefei 11
Chennai 10
Denver 10
Glasgow 10
Guangzhou 10
Manchester 10
Phoenix 9
San Mateo 9
Syracuse 9
Chicago 8
Milan 8
Montreal 8
Rome 8
Tokyo 8
Tramatza 8
Vienna 8
Brooklyn 7
Changsha 7
Curitiba 7
Dolianova 7
Nanjing 7
Nottingham 7
Taipei 7
Bacolod City 6
Cairo 6
Central 6
Düsseldorf 6
Falls Church 6
Istanbul 6
Johannesburg 6
Mumbai 6
Nuremberg 6
Paris 6
Rio de Janeiro 6
San Diego 6
San Francisco 6
Sydney 6
Toronto 6
Bangkok 5
Brno 5
Bucharest 5
Cape Town 5
Haiphong 5
Melbourne 5
Perham 5
Shenyang 5
Auburn 4
Cagayan de Oro 4
Da Nang 4
Edgemont 4
Falkenstein 4
Galatina 4
Jena 4
Monmouth Junction 4
Totale 66.750
Salva come PNG Salva come JPEG
Nome #
Efficacy and safety of the 5-Hydroxytryptophan on Levodopa-Induced Motor Complications in Parkinson's disease 24.356
C9ORF72 intermediate repeat expansion in patients affected by atypical Parkinsonian syndromes or parkinson’s disease complicated by psychosis or dementia in a Sardinian population 4.286
The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease 4.081
Efficacy and safety of the 5-Hydroxytryptophan on Depression and Apathy in Parkinson's disease: a preliminary finding 3.346
Pisa-Like Syndrome Under Baclofen in a Patient With Spastic Hemiparesis due to Ischemic Stroke 3.181
Focal 123I-FP-CIT SPECT abnormality in a patient with midbrain vascular Parkinsonism 3.100
Efficacy and safety of 5-Hydroxytryptophan on levodopa-induced motor complications in Parkinson's disease: A preliminary finding 2.368
Efficacy and Safety of the 5-Hydroxytryptophan on REM Sleep Behavior Disorder in Parkinson's Disease 2.269
Severity of REM sleep without atonia (RSWA) correlates with cognitive functions in patients with REM sleep behaviour disorder (RBD) 2.201
Efficacy and safety of the 5-Hydroxytryptophan on Depression and Apathy in Idiopathic Parkinson's disease 2.166
Neuropsychological and behavioral profile of patients with isolated REM sleep behaviour disorders (iRBD) and patients with RBD associated with Parkinson's Disease (PDRBD) 2.129
Association between dopaminergic medications and REM sleep behavior disorder in Parkinson’s disease: a preliminary cohort study 1.759
Does REM sleep behavior disorder change in the progression of Parkinson’s disease? 1.703
Diagnosing REM sleep behavior disorder in Parkinson's disease without a gold standard: a latent-class model study 1.523
A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Safety and Efficacy of the 5-Hydroxytryptophan on REM Sleep Behavior Disorder, Levodopa-Induced Motor Complications and Neuropsychiatric Disorders in Idiopathic Parkinson's disease. 1.480
DIAGNOSING REM SLEEP BEHAVIOUR DISORDER IN PARKINSON DISEASE WITHOUT A GOLD STANDARD: A LATENT CLASSES MODELS STUDY 1.374
Does REM Sleep Behavior Disorder Change in the Progression of Parkinson’s Disease? 1.361
REM sleep behavior disorder changes in the progression of Parkinson's disease: a longitudinal study 1.343
Cognitive and Behavioral features of isolated Rem Sleep Bhaviour disorders (IRBD) and RBD associated with Parkinson's disease (PDRBD 1.050
Neurophysiological features of REM sleep Behaviour Disorder (RBD) correlate with cognitive and psycho-behavioral profile 963
Preliminary finding of a randomized, double-blind, placebo-controlled, crossover study to evaluate the safety and efficacy of 5-hydroxytryptophan on REM sleep behavior disorder in Parkinson's disease 837
Severity of REM sleep without atonia correlates with measures of cognitive impairment and depressive symptoms in REM sleep behaviour disorder 580
Considering REM Sleep Behavior Disorder in the Management of Parkinson's Disease 524
Oligomeric Alpha-Synuclein and STX-1A from Neural-Derived Extracellular Vesicles (NDEVs) as Possible Biomarkers of REM Sleep Behavior Disorder in Parkinson's Disease: A Preliminary Cohort Study 415
Oligomeric α-synuclein and tau aggregates in NDEVs differentiate Parkinson's disease from atypical parkinsonisms 72
Totale 68.467
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.837
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.837
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021334 0 0 0 0 0 0 0 0 0 0 0 334
2021/20222.874 290 229 186 143 214 288 281 126 181 297 269 370
2022/20233.611 366 509 495 325 317 280 171 214 215 218 348 153
2023/20243.703 119 129 140 250 356 519 551 253 146 240 460 540
2024/202528.284 12.124 4.952 9.001 692 375 367 409 61 95 63 71 74
2025/20261.793 201 73 157 178 152 164 333 105 153 179 68 30
Totale 68.467